These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19525094)

  • 1. VEB-6 extended-spectrum beta-lactamase-producing Proteus mirabilis from Sultanate of Oman.
    Potron A; Poirel L; Elhag K; Al Yaqoubi F; Nordmann P
    Int J Antimicrob Agents; 2009 Nov; 34(5):493-4. PubMed ID: 19525094
    [No Abstract]   [Full Text] [Related]  

  • 2. The first detection of CTX-M-14 extended-spectrum beta-lactamase among diverse beta-lactamase-producing Proteus mirabilis clinical isolates.
    Yong D; Lim YS; Roh KH; Choi YS; Park DY; Yum JH; Kim JM; Lee K; Chong Y
    Diagn Microbiol Infect Dis; 2006 Mar; 54(3):237-9. PubMed ID: 16427241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of Proteus mirabilis isolates producing TEM-52 extended-spectrum beta-lactamases in Croatia.
    Sardelić S; Bedenić B; Sijak D; Colinon C; Kalenić S
    Chemotherapy; 2010; 56(3):208-13. PubMed ID: 20551637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The incidence of extended spectrum beta-lactamases in Proteus mirabilis strains isolated in 2007-2009].
    Kwiecińska-Piróg J; Bogiel T; Gospodarek E
    Przegl Epidemiol; 2010; 64(3):395-8. PubMed ID: 20976952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of extended-spectrum (beta)-lactamases and plasmid-mediated AmpC (beta)-lactamases among Korean isolates of Proteus mirabilis.
    Park YJ; Lee S; Kim YR; Oh EJ; Woo GJ; Lee K
    J Antimicrob Chemother; 2006 Jan; 57(1):156-8. PubMed ID: 16284101
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular epidemiology of CTX-M-type extended-spectrum β-lactamase-producing Proteus mirabilis isolates in Taiwan.
    Huang CW; Chien JH; Peng RY; Tsai DJ; Li MH; Lee HM; Lin CF; Lee MC; Liao CT
    Int J Antimicrob Agents; 2015 Jan; 45(1):84-5. PubMed ID: 25446905
    [No Abstract]   [Full Text] [Related]  

  • 7. First description of DHA-1 ampCbeta-lactamase in Proteus mirabilis.
    Bidet P; Verdet C; Gautier V; Bingen E; Arlet G
    Clin Microbiol Infect; 2005 Jul; 11(7):591-2. PubMed ID: 15966982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of bacteremia caused by extended-spectrum beta-lactamase-producing Proteus mirabilis.
    Kurihara Y; Hitomi S; Oishi T; Kondo T; Ebihara T; Funayama Y; Kawakami Y
    J Infect Chemother; 2013 Oct; 19(5):799-805. PubMed ID: 23371453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outbreak caused by Proteus mirabilis isolates producing weakly expressed TEM-derived extended-spectrum β-lactamase in spinal cord injury patients with recurrent bacteriuria.
    Cremet L; Bemer P; Rome J; Juvin ME; Navas D; Bourigault C; Guillouzouic A; Caroff N; Lepelletier D; Asseray N; Perrouin-Verbe B; Corvec S
    Scand J Infect Dis; 2011 Dec; 43(11-12):957-61. PubMed ID: 21888562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of Proteus mirabilis carrying the bla metallo-beta-lactamase gene.
    Vourli S; Tsorlini H; Katsifa H; Polemis M; Tzouvelekis LS; Kontodimou A; Vatopoulos AC
    Clin Microbiol Infect; 2006 Jul; 12(7):691-4. PubMed ID: 16774572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management.
    Luzzaro F; Brigante G; D'Andrea MM; Pini B; Giani T; Mantengoli E; Rossolini GM; Toniolo A
    Int J Antimicrob Agents; 2009 Apr; 33(4):328-33. PubMed ID: 19095415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in biofilm formation and aggregative adherence between beta-lactam susceptible and beta-lactamases producing P. mirabilis clinical isolates.
    Nucleo E; Fugazza G; Migliavacca R; Spalla M; Comelli M; Pagani L; Debiaggi M
    New Microbiol; 2010 Jan; 33(1):37-45. PubMed ID: 20402412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging extended-spectrum beta-lactamases in Proteus mirabilis.
    Pagani L; Migliavacca R; Pallecchi L; Matti C; Giacobone E; Amicosante G; Romero E; Rossolini GM
    J Clin Microbiol; 2002 Apr; 40(4):1549-52. PubMed ID: 11923394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged bacteraemia caused by VIM-1 metallo-beta-lactamase-producing Proteus mirabilis: first report from Italy.
    Falcone M; Perilli M; Mezzatesta ML; Mancini C; Amicosante G; Stefani S; Venditti M
    Clin Microbiol Infect; 2010 Feb; 16(2):179-81. PubMed ID: 19624511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ulcer infection by ESbetaL-producing Proteus mirabilis: a case report.
    Savini V; Catavitello C; Talia M; Di Berardino F; Manna A; Balbinot A; Febbo F; Carlino D; Fioritoni F; Di Bonaventura G; D'Antonio D
    Int J Low Extrem Wounds; 2008 Jun; 7(2):99-101. PubMed ID: 18483010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical epidemiology of ciprofloxacin-resistant Proteus mirabilis isolated from urine samples of hospitalised patients.
    Saito R; Okugawa S; Kumita W; Sato K; Chida T; Okamura N; Moriya K; Koike K
    Clin Microbiol Infect; 2007 Dec; 13(12):1204-6. PubMed ID: 17850340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular diversity of Proteus mirabilis isolates producing extended-spectrum beta-lactamases in a French university hospital.
    Biendo M; Thomas D; Laurans G; Hamdad-Daoudi F; Canarelli B; Rousseau F; Castelain S; Eb F
    Clin Microbiol Infect; 2005 May; 11(5):395-401. PubMed ID: 15819867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. F2:A-:B- plasmid carrying the extended-spectrum β-lactamase bla(CTX-M-55/57) gene in Proteus mirabilis isolated from a primate.
    Dahmen S; Madec JY; Haenni M
    Int J Antimicrob Agents; 2013 Jun; 41(6):594-5. PubMed ID: 23507413
    [No Abstract]   [Full Text] [Related]  

  • 19. High prevalence and molecular characterization of extended-spectrum β-lactamase-producing Proteus mirabilis strains in southern Croatia.
    Tonkić M; Mohar B; Šiško-Kraljević K; Meško-Meglič K; Goić-Barišić I; Novak A; Kovačić A; Punda-Polić V
    J Med Microbiol; 2010 Oct; 59(Pt 10):1185-1190. PubMed ID: 20558587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteus mirabilis harboring carbapenemase NDM-5 and ESBL VEB-6 detected in Austria.
    Valentin T; Feierl G; Masoud-Landgraf L; Kohek P; Luxner J; Zarfel G
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):284-286. PubMed ID: 29571841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.